Washington, D.C. – February 25, 2026 – Commitment to Seniors, a project of American Commitment, applauds President Trump for addressing abusive insurer practices and urging lawmakers to rein in rising health care costs during last night’s State of the Union. However, we strongly oppose any effort to codify the administration’s Most Favored Nation (MFN) drug pricing proposal into law.
By tying U.S. reimbursement rates to prices set by socialist-style foreign governments, MFN would undermine the market-based incentives responsible for developing new cures. These policies also risk importing the same health care access barriers seniors routinely face abroad, including delays in accessing innovative treatments.
Instead, the President should continue its efforts to crack down on powerful insurers and their middlemen, who have pocketed billions in profits while seniors face skyrocketing premiums and rising out-of-pocket costs. Advancing patient-first reforms that increase transparency, restore competition, and combat abusive PBM and insurer practices will do far more to lower costs without sacrificing innovation.
“We commend President Trump’s remarks during the State of the Union on addressing insurer-driven cost increases and working to lower health care costs for all American patients,” said Jon Decker, Executive Director of American Commitment. “But importing foreign drug price controls through Most Favored Nation is the wrong approach. This policy risks limiting access to lifesaving treatments and weakening America’s leadership in medical discovery. Instead, we strongly encourage the administration to continue prioritizing reforms that ensure accountability, protect patients, and preserve the incentives that drive medical progress.”